EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
1.14.99.1 | Aberrant Crypt Foci |
11782374 |
Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. |
causal interaction diagnostic usage therapeutic application unassigned |
4 3 4 0 |
1.14.99.1 | Aberrant Crypt Foci |
11911260 |
Evaluation of a selective prostaglandin E receptor EP1 antagonist for potential properties in colon carcinogenesis. |
ongoing research therapeutic application unassigned |
2 4 0 |
1.14.99.1 | Aberrant Crypt Foci |
12148579 |
Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane. |
ongoing research unassigned |
3 0 |
1.14.99.1 | Aberrant Crypt Foci |
14583451 |
Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic transforming growth factor beta and cyclooxygenase isoforms in Zucker obese (fa/fa) rats. |
causal interaction diagnostic usage ongoing research unassigned |
1 4 1 0 |
1.14.99.1 | Aberrant Crypt Foci |
14643021 |
Chemopreventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on 1, 2-dimethylhydrazine-induced rat colon carcinogenesis. |
causal interaction ongoing research therapeutic application unassigned |
4 2 4 0 |
1.14.99.1 | Aberrant Crypt Foci |
14971826 |
Fructooligosaccharide associated with celecoxib reduces the number of aberrant crypt foci in the colon of rats. |
ongoing research unassigned |
3 0 |
1.14.99.1 | Aberrant Crypt Foci |
15069535 |
Inhibitory effects of etodolac, a selective COX-2 inhibitor, on the occurrence of tumors in colitis-induced tumorigenesis model in rats. |
causal interaction ongoing research therapeutic application unassigned |
3 4 4 0 |
1.14.99.1 | Aberrant Crypt Foci |
15244513 |
Indian food ingredients and cancer prevention - an experimental evaluation of anticarcinogenic effects of garlic in rat colon. |
causal interaction therapeutic application unassigned |
4 3 0 |
1.14.99.1 | Aberrant Crypt Foci |
15300575 |
Glutathione-S-transferase P1-1 protects aberrant crypt foci from apoptosis induced by deoxycholic acid. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 3 4 2 |
1.14.99.1 | Aberrant Crypt Foci |
15455344 |
JTE-522, a selective cyclooxygenase-2 inhibitor, inhibits induction but not growth and invasion of 1,2-dimethylhydrazine-induced tubular adenocarcinomas of colon in rats. |
causal interaction ongoing research therapeutic application unassigned |
3 2 3 0 |